Open AccessAssessing the association between GLP-1 receptor agonist use and diabetic retinopathy through the FDA adverse event reporting system
Author(s) -
T. Wang,
W. Lu,
H. Tang,
J.B. Buse,
T. Stürmer,
E.W. Gower
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/6egs-0964
Subject(s) - diabetic retinopathy , agonist , adverse effect , medicine , glucagon like peptide 1 receptor , pharmacology , adverse event reporting system , diabetes mellitus , receptor , endocrinology